Zooming in on the auditory cortex, the researchers found three unique sets of neurons that light up while we listen to music.

The acquisition announcement came alongside the reveal of a Phase III failure for Roche’s TIGIT asset tiragolumab, which when ...

But, like all behavioral care providers, Acclaim Autism has faced technological and operational challenges, among them an ...

Columnist Teri Sforza writes that a treatment empire keeps going, even as state regulators accuse operators of endangering ...

The Lehigh Valley Topper Cancer institute has announced that it is now offering treatment using autologous chimeric antigen ...

If you love your tub and wouldn’t buy a house without a soaking section if your life depended on it, there is some good news — the story of the disappearing bathtub is more about evolution than ...

A woman has been left feeling devastated after she stumbled across secret notes on her husband's phone that he wrote about ...

The RC Week 24 was organized by the unit of Respiratory Therapy Yenepoya School of Allied Health Sciences (YSAHS), and took ...

Pending the FDA’s decision, compounding pharmacies will remain free to make and market versions of the blockbuster ...

Authorization is based on results from the Phase 3 CARTITUDE-4 (MMY3002) study, which showed treatment with CARVYKTI® reduced the risk of disease progression or death by 74 per cent compared to ...

New research suggests that short-term hormone therapy for menopause symptoms does not have long-term cognitive effects, whether harmful or beneficial.

First-of-Its-Kind Success in Mismatched Donor Stem Cell Transplantation: Engraftment Under Mild Immune Suppression with Minimal Graft-versus-Host DiseaseNEW YORK, NY / ACCESSWIRE / November 21, 2024 / ...